Temporal Changes in Sonographic Findings as Predictors of Disease Severity in Crimean-Congo Hemorrhagic Fever.

Venturing into host-pathogen interaction in Crimean-Congo hemorrhagic fever to highlight terra incognita.

CCHFV Seroprevalence among Hunter-Gatherers, Northeastern Democratic Republic of the Congo.

Immunoreactivity of pan MHC-I epitopes on Crimean-Congo hemorrhagic fever virus glycoprotein C-terminal.

Accuracy of rapid and near-patient diagnostics for detection of rift valley fever and Crimean-Congo haemorrhagic Fever infections: A systematic review and meta-analysis.

Bridging the gap: ex vivo human skin explants for mechanistic studies of arboviruses.

The contribution of viral toxins to infection and pathogenesis.

Prognostic accuracy of severity grading score and severity scoring index for predicting severe outcomes in Crimean-Congo hemorrhagic fever: a systematic review and meta-analysis.

Host Community Traits Driving Crimean-Congo Hemorrhagic Fever Virus Maintenance in Iberian Ecosystems.

Assessment of Butchers' Awareness, Attitude, and Occupational Practices Toward Crimean-Congo Hemorrhagic Fever (CCHF) in Kabul, Afghanistan: A Cross-Sectional Study.

CRISPR-Based Detection of Viral Hemorrhagic Fevers at the Point of Care.

Microbiological perspectives on Crimean-Congo hemorrhagic fever: Seroprevalence and viral pathogenesis in Iraq.

Prognostic value of sCD163, IL-6, PLR, and SII in predicting disease severity in Crimean-Congo hemorrhagic fever: a prospective study.

Repurposing Cilnidipine as an entry inhibitor against Crimean-Congo Hemorrhagic Fever pseudovirus infection.

Machine learning-based mortality prediction models for Crimean-Congo hemorrhagic fever patients.

Seasonal patterns of Crimean-Congo hemorrhagic fever in Afghanistan: environmental factors and public health implications, 2022-2024.

Differences in cynomolgus macaque populations used for infectious disease research.

Development and Characterization of Microsatellite Genetic Markers for Hyalomma rufipes, a Tick Vector of Crimean-Congo Hemorrhagic Fever Virus.

GP38 is a structural component of Crimean-Congo hemorrhagic fever virus particles.

Amino Terminal Region of Crimean-Congo Hemorrhagic Fever Virus (CCHFV) Nucleocapsid (NP) Protein Contains Dominant Epitopes Recognised by Cellular Immunity.

High Seroprevalence and Risk Factors of Crimean-Congo Hemorrhagic Fever Virus in Camels at Livestock Markets in Border Regions, Nigeria, 2023-2024.

Crimean-congo hemorrhagic fever in Iraq, 2021-2024: epidemiological and clinical data analysis with proposed severity indicators for resource-constrained settings.

Targeted organic acid profiling in Crimean-Congo hemorrhagic fever: A metabolomics-based approach to biomarker discovery.

First Detection of Jingmen Tick Virus in Hard Ticks Collected Across Multiple Regions of Italy.

The Outcome of PCR Versus IGM Timing Study in the Diagnosis of the Crimean-Congo Hemorrhagic Fever Outbreak in Iraq during 2021-2022.

From pandemic influenza to novel coronaviruses: emerging infectious diseases of the 21st century.

New markers predicting prognosis in patients with Crimean-Congo hemorrhagic fever: HDL cholesterol and eosinophil levels.

Hospital preparedness and operational adaptation for the safe management of Crimean-Congo haemorrhagic fever patients.

Field vaccination against CCHFV and Hyalomma tick infestation reduces multiple tick-borne infections in sheep.

In Silico Analysis of Potential Vaccine Antigens for the Treatment of Crimean-Congo Hemorrhagic Fever Virus (Cchfv).

Identification and classification of Crimean-Congo hemorrhagic fever virus from Hyalomma asiaticum from southern Mongolia.

Crimean-Congo hemorrhagic fever: serum neopterin levels and their relationship with clinical course.

Structure and function of the nairovirus cap-snatching endonuclease.

Identification of claramine and anidulafungin as entry inhibitors of Crimean-Congo hemorrhagic fever virus.

Discrimination of Hard Ticks by Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP).

Inhibitory effects of molnupiravir on Crimean-Congo hemorrhagic fever virus polymerase.

Thermodynamic Analysis of the Stability of the Crimean-Congo Hemorrhagic Fever Virus on Inanimate Surfaces.

A Compendium Review of the Global Epidemiology of Ticks and Tick-borne Diseases: Regional Insights from Türkiye.

A multisectoral effort against Crimean-Congo hemorrhagic fever: Towards One Health approach implementation in the Balkans and Black Sea region.

Co-Circulation of Tick-Borne Bandaviruses and Orthonairoviruses Across Humans, Livestock, and Rats in Pakistan: Serologic Evidence and Public Health Implications.

Seroprevalence of Crimean-Congo Hemorrhagic Fever and Rift Valley Fever Viruses Among Ruminants in Nigeria: A Descriptive Epizootiological Analysis.

Serologic Evidence of Circulation of Six Arboviruses (Dengue Virus, Chikungunya Virus, Zika Virus, Rift Valley Virus, Yellow Fever Virus, Crimean-Congo Hemorrhagic Fever Virus) in Four Regions of Burkina Faso, West Africa.

Transforming One Health in India: National Multisectoral Mixed Method Study on Prioritization of Zoonotic Diseases.

Active transmission of Crimean-Congo Hemorrhagic fever virus, a tick-borne disease, in Iraq: Animal host population movement dynamics and retrospective case study analysis (2018-2023).

An Overview of the Crimean-Congo Hemorrhagic Fever Outbreak in Iraq.

Spatiotemporal and clinical dynamics of Crimean-Congo Hemorrhagic Fever in Wasit Governorate, Iraq (2022-2025): a retrospective analytical study.

Crimean-Congo hemorrhagic fever: An emerging threat in Europe.

Detection of Crimean-Congo hemorrhagic fever virus and Rift Valley fever virus antibodies in animal workers in Cameroon.

Pathogenicity of a novel orthonairovirus, Iwanai Valley virus, in mice.

The first detection of Jingmen tick virus (JMTV) in humans in Türkiye, 2022.

A single-dose mRNA vaccine protects mice from lethal Crimean-Congo hemorrhagic fever virus infection.

Crimean-Congo Hemorrhagic Fever Virus in Cattle and Ticks, Israel.

Electrochemical immunosensor for sensitive detection of Crimean-Congo hemorrhagic fever virus based on a flexible electrode of carbon nanofibers modified with copper (II) phosphate nanoflowers.

Comparison of Blood Parameters in Crimean-Congo Hemorrhagic Fever and Upper Respiratory Infection Patients with Similar Complaints.

Neutralization of Crimean-Congo hemorrhagic fever pseudotyped virions with heavy chain antibodies.

Seroprevalence of four zoonotic viral diseases in camels in Qatar.

The risk of human- and mammal-infecting tick-borne viruses in northwest China and adjacent countries.

Crimean-Congo hemorrhagic fever virus localization and shedding in the reproductive tract of lethal and survivor mouse models.

Chemical composition and acaricidal properties of essential oils from Cinnamomum mollifolium, Eucalyptus globulus, and Pimenta dioica against Hyalomma rufipes (Acari: Ixodidae).

Oral VV261 administration protects mice from lethal Crimean-Congo hemorrhagic fever virus challenge.

GenBank2PubMed: bridging viral genomic data and the scientific literature with AI-assisted curation.

RNA virome of ticks and fleas infesting Marmota himalayana from the Qinghai-Tibet plateau.

Durable humoral immunity and long-term protection induced by a Crimean-Congo hemorrhagic fever virus replicon particle vaccine in mice.

Diversity, distribution, and climate change impacts on tick fauna in Saudi Arabia: A comprehensive ecological niche modeling approach.

Genetic features of Orthonairovirus haemorrhagiae variants detected in ixodid ticks in Armenia.

Descriptive Epidemiology of Acute Febrile Illness Patients in Nigeria: Pathogens of Global Public Health Significance Detected Using a Multi-Pathogen Detection Tool.

Brucellosis Seroprevalence and Diagnostic Challenges: A Comprehensive Review from 2017-2021.

Pathogenesis of Hazara orthonairovirus infection in type I interferon receptor-deficient mice and resolution of disease following 4'-fluorouridine therapy.

Epidemiology of the Crimean-Congo hemorrhagic fever virus.

Viral hemorrhagic fevers - therapeutic trial advances and challenges.

Serosurveillance of Crimean-Congo hemorrhagic fever virus in zoo animals, Spain, 2007-2024.

Design, synthesis and preliminary biological evaluation of novel carbamoyl pyridone derivatives as potent inhibitors of Crimean-Congo hemorrhagic fever virus.

Phenotypic and genetic changes of Crimean-Congo hemorrhagic fever virus during serial passage in susceptible cell lines.

Crimean-Congo hemorrhagic fever virus NSm protein inhibits the type I interferon signaling by binding to STAT2.

Abdominal computed tomography findings in Crimean-Congo hemorrhagic fever: correlations with disease severity and prognostic implications.

[Spinal Epidural Abscess and Spondylodiscitis Following Crimean-Congo Hemorrhagic Fever: A Rare Post-Recovery Complication].

Acute Hepatic Failure in Crimean-Congo Hemorrhagic Fever: A Case Report.

First Serological Evidence of Crimean-Congo Hemorrhagic Fever Virus Infections in Croatia: A Multispecies Surveillance Approach Emphasising the Role of Sentinel Hosts.

Prognostic Significance of CRP/Albumin, D-Dimer/Albumin, D-Dimer/Fibrinogen Ratios and Triglyceride-Glucose Index in Crimean-Congo Hemorrhagic Fever: A Prospective Observational Study.

Serologic evidence of crimean-congo hemorrhagic fever virus exposure among livestock and farmers in the Democratic Republic of the Congo.

Genetic evidence of regional circulation of Crimean-Congo hemorrhagic fever virus in ixodid ticks from southern Kazakhstan.

Crimean-Congo Hemorrhagic Fever Disease: Relationship Between Clinical Course and Apoptosis.

Comparative evaluation of a multiplex polymerase chain reaction panel for high-consequence infectious diseases against conventional diagnostics in travelers with febrile diseases.

A non-fatal Crimean-Congo hemorrhagic fever virus infection; The balanced cytokine responses on the outcome of the clinical disease.

Tracking invasion events: phylogeography of Hyalomma marginatum in the Mediterranean basin with a focus on Southern France.

Evidence of Crimean-Congo hemorrhagic fever (CCHF) susceptibility among big felids in Namibia: leopards (Panthera pardus) and lions (Panthera leo).

Striking tick-borne virus diversity and potential reservoirs documented during One-Health-based cross-sectional screening in Anatolia.

A fatal case of Herpes simplex virus-2 infection imported from Sharjah to India: Need for differential diagnosis amid Mpox surveillance.

Genetic Diversification of Crimean-Congo Hemorrhagic Fever Virus Lineage Europe 1.

Crimean-Congo Hemorrhagic Fever Virus Circulation in Wild European Rabbits, Portugal, 2018-2023.

Multicriteria Decision Analysis as a Tool for Assessing Vector-Borne Diseases Risk: The Case of Crimean-Congo Hemorrhagic Fever in Türkiye.

The first finding of Hyalomma rufipes in Poland in 2024: the promising start of a citizen science project.

First detection of Crimean Congo Hemorrhagic Fever antibodies in cattle and wildlife of southern continental France: Investigation of explanatory factors.

Crimean-Congo hemorrhagic fever virus Africa 1 lineage in Hyalomma species ticks, Tunisia, 2024.

Silent killer strikes during Eid-Ul-Adha: Crimean-Congo hemorrhagic fever outbreak in Khyber Pakhtunkhwa, Pakistan, 2023.

Development of a Rapid Diagnostic Test to Distinguish between Emerging Viruses That Cause Hemorrhagic Fever.

An orally available 4'-fluorouridine prodrug inhibits SFTSV and LCMV infection.

Evaluation of Clinical and Hematological Findings of Pediatric Patients with Crimean-Congo Hemorrhagic Fever.

CCHFV-M based DNA vaccine is highly immunogenic in multiple species and protects against challenge in cynomolgus macaques.

Crimean-Congo Hemorrhagic Fever Accompanied by Acalculous Cholecystitis and Pancytopenia: A Rare Case.

The first reported Crimean-Congo hemorrhagic fever reinfection in the literature: 11 years apart.

Identification and Structural Characterization of Viroporins from Deadly Hemorrhagic Viruses.

Molecular Evolution and Phylogeography of the Crimean-Congo Hemorrhagic Fever Virus.

Molecular and Clinical Characterization of Crimean-Congo Hemorrhagic Fever in Bulgaria, 2015-2024.

Tick-Borne Pathogens in Companion Animals and Zoonotic Risk in Portugal: A One Health Surveillance Approach.

Identification of Hyalomma Ticks on Migratory Birds in Poland During the 2023 and 2024 Spring Seasons.

Decoding blood fatty acids in Crimean-Congo hemorrhagic fever.

Soluble MFGE8 mediates cell entry of Crimean-Congo hemorrhagic fever virus.

Stability of the Crimean-Congo Hemorrhagic Fever Virus on Inanimate Surfaces and Implications for Infection Control.

Epigenetic modulation of ALKBH5, FTO and YTHDF2 genes in crimean-congo haemorrhagic fever patients depending on RNA methylation.

Relationship between vascular endothelial growth factor gene polymorphisms and Crimean-Congo hemorrhagic fever.

Genetic Variations in Crimean-Congo Hemorrhagic Fever Virus: Challenges for Molecular Diagnostic Assays-A Case Report.

sVEGFR1 up-regulation via EGR1 impairs vascular repair in SFTSV-induced hemorrhage.

Hyalomma marginatum in Europe: The Past, Current Status, and Future Challenges-A Systematic Review.

Drivers of Crimean-Congo Hemorrhagic Fever in Natural Host and Effects of Control Measures, Bulgaria.

ZFP36L1 and L2 as novel antiviral factors for Crimean-Congo hemorrhagic fever virus via interaction with viral nucleoprotein.

Highly sensitive and multiplex detection of nine potential bioterrorism viral agents in a single reaction by multiplex probe amplification (MPA) with melting curve analysis.

Chest computed tomography assessment of patients with crimean- congo hemorrhagic fever: a comparison between survivors and nonsurvivors.

Harnessing Hazara Virus as a Surrogate for Crimean-Congo Hemorrhagic Fever Virus Enables Inactivation Studies at a Low Biosafety Level.

Tick-Borne Viruses in a Changing Climate: The Expanding Threat in Africa and Beyond.

In-silico study: Hm86 protein of Hyalomma marginatum (Ixodida) as a candidate to provide anti-tick vaccine.

Rapid, sensitive, and species-independent detection of Crimean Congo hemorrhagic fever virus nucleoprotein and GP38 antibodies.

Seroprevalence of Rift Valley and Crimean-Congo Hemorrhagic Fever Viruses, Benin, 2022-2023.

Crimean-Congo Hemorrhagic Fever Virus among Goats, Southern Bhutan.

Crimean-Congo Hemorrhagic Fever Virus Africa 1 Lineage in Hyalomma dromedarii Ticks, Algeria, 2023.

A comprehensive review on the epidemiology of arboviruses in the Eastern Mediterranean Region (EMRO): insights from the WHO's Regional Office.

A Case of Crimean-Congo Hemorrhagic Fever Presenting to the Emergency Department with Postmenopausal Vaginal Bleeding.

Evidence of Crimean-Congo hemorrhagic fever virus in livestock and wildlife in Northeastern Portugal.

Crimean-Congo Hemorrhagic Fever Outbreak in Podor, Northern Senegal in 2022: Two Independent Emergences and Unprecedented Mortality.

Tick-Borne Infectious Diseases in China, 2003-2023.

Rapid laboratory confirmation of the 2025 Sudan Virus Disease (Svd) index case in Uganda.

Seroprevalence and factors associated with CCHF virus infection in cattle and sheep in Mopti region (Mali).

Insights into Crimean-Congo hemorrhagic fever virus exposure probability: a period cross-sectional study in wild and domestic ungulates.

First report of Crimean-Congo hemorrhagic fever virus exposure in human and livestock populations, Center Region, Cameroon.

The Single Amino Acid Change of R516K Enables Efficient Generation of Vesicular Stomatitis Virus-Based Crimean-Congo Hemorrhagic Fever Reporter Virus.

Seroprevalence study for selected zoonotic vector-borne pathogens in sheep from endemic areas of Croatia.

NMR side-chain assignments of the Crimean-Congo hemorrhagic fever virus glycoprotein n cytosolic domain.

Immunogenicity of NSDV GP38 and the role of furin in GP38 proteolytic processing.

Human tick biting and tick-borne disease risk in Türkiye: Systematic review.

Factors associated with knowledge, attitudes, and practices of mixed crop-livestock farmers on Crimean-Congo hemorrhagic fever (CCHF) and other zoonoses in Burkina Faso.

Serosurveillance of Crimean-Congo hemorrhagic fever virus antibodies in livestock as a reservoir for human infection in Afghanistan.

Fatal Crimean-Congo Hemorrhagic Fever with an Atypical Clinical Course during the COVID-19 Pandemic.

Detecting spatial clusters of Crimean Congo hemorrhagic fever in Iraq in 2023.

Treatment and management of Crimean-Congo hemorrhagic fever.

Zoonotic arbovirus infections in cattle in Mozambique with special reference to Crimean-Congo hemorrhagic fever virus (CCHFV) and rift valley fever virus (RVFV).

Exploring approaches and advancements in the development and evaluation of multi-epitope subunit vaccines against tick-borne viruses.

Crimean-Congo hemorrhagic fever with severe bradycardia treated with Theophylline.

Single dose VSV-based vaccine protects mice against lethal heterologous Crimean-Congo hemorrhagic fever virus challenge.

Successful Inactivation of High-Consequence Pathogens in PrimeStore Molecular Transport Media.

Persistent Infections in Tick Cell Lines: The Role of Viral-Derived DNA Forms in Hazara Virus Replication and Cellular Survival.

Association Between IL-28B (rs8099917) and IL-28B (rs12979860) with Predisposition to Diseases Related to the HTLV-1: Systematic Review and Meta-Analysis.

Elevated interferon-induced transmembrane protein 3 in platelets and megakaryocytes suppresses Crimean-Congo hemorrhagic fever viral infection by interacting with glycoprotein Gc.

Semi-automated diagnostic RT-PCR as a screening assay for antiviral compounds in a 96-well format against highly pathogenic RNA viruses.

Crimean-Congo Hemorrhagic Fever Virus Infections in Slaughtered Camels and Abattoir Workers in the United Arab Emirates.

Mucin-like protein of Crimean-Congo hemorrhagic fever virus is a key virulence factor and a potent target for developing novel attenuated vaccine.

Deaths in animal attacks: A 10-year retrospective forensic analysis of direct and indirect causes.

Spatio-temporal distribution of Crimean-Congo Hemorrhagic Fever and its relationship with climate factors in Pakistan: A decade-long experience from tertiary care laboratory network.

Re-emergence of Crimean Congo hemorrhagic fever virus in Kedougou, south-eastern Senegal in 2023: Epidemiological and zoological investigations of the first symptomatic human case.

The nucleocapsid protein of Crimean-Congo hemorrhagic fever virus interacts with eIF4A to promote the translation of viral mRNA in cells.

A mouse model of Crimean-Congo hemorrhagic fever virus-induced coagulopathy.

Outbreak of Crimean-Congo hemorrhagic fever in Kyzylorda region, Kazakhstan, March-July 2022.

CO-OCCURRENCE OF HANTAVIRUS PULMONARY SYNDROME AND HEMORRHAGIC FEVER WITH RENAL SYNDROME.

Exposure to Crimean-Congo Hemorrhagic Fever Virus in Wild Ungulates in the Basque Country, Northern Iberian Peninsula.

Evaluation of a Luminex-Based Multiplex Immunoassay of Hemorrhagic Fever Viruses in Senegal.

Host genetic diversity contributes to disease outcome in Crimean-Congo hemorrhagic fever virus infection.

Prognostic Value of Ratios of Inflammatory Markers in the Prognosis of Crimean-Congo Hemorrhagic Fever.

The Growing Threat of Tick-Borne Viruses: Global Trends, Clinical Outcomes, and Diagnostic Strategies.

Prime-Boost Vaccination Based on Nanospheres and MVA Encoding the Nucleoprotein of Crimean-Congo Hemorrhagic Fever Virus Elicits Broad Immune Responses.

A case report and mini-review of Crimean-Congo hemorrhagic fever with encephalitis: an unexpected complication.

Mechanisms of action of repurposed Ebola virus antivirals - the roles of phospholipidosis and cholesterol homeostasis.

Avidity and variable domain spacing strongly influence the therapeutic potency of bispecific antibodies against Crimean-Congo hemorrhagic fever virus.

Serological evaluation of Crimean-Congo Hemorrhagic fever in humans with High-Risk professional exposure and in residual sera collected in 2022-2023 across Corsica (France).

A replicating RNA vaccine confers protection against Crimean-Congo hemorrhagic fever in cynomolgus macaques.

Prevalence Rates and Outcomes of Hyponatremia in Patients with Crimean-Congo Hemorrhagic Fever.

Development of FRET-based cap-snatching endonuclease assay.

Seroprevalence and Risk Factors of Crimean-Congo Hemorrhagic Fever Exposure in Wild and Domestic Animals in Benin.

Crimean-Congo hemorrhagic fever: Pathogenesis, transmission and public health challenges.

Author Correction: Spatial analysis and risk mapping of Crimean-Congo hemorrhagic fever (CCHF) in Sub-Saharan Africa.

Mapping the potential suitable habitats for Hyalomma rufipes (Acari: Ixodidae) in Africa and Western Eurasia.

Drug repositioning as a promising approach for the eradication of emerging and re-emerging viral agents.

Predictive role of non-viral leukocyte parameters in tracking the development and progression of Crimean-Congo hemorrhagic fever.

Kaempferide enhances type I interferon signaling as a novel broad-spectrum antiviral agent.

[Specific precautions against Crimean-Congo hemorrhagic fever in patients with general symptoms after a tick bite].

Molecular characterization and phylogenetic analysis of Crimean-Congo hemorrhagic fever virus, northwestern of Iran.

Crimean-Congo hemorrhagic fever, a real health problem in Iraq?

Emerging Arboviral Diseases in Pakistan: Epidemiology and Public Health Implications.

Crimean-Congo Hemorrhagic Fever Mimicking HELLP Syndrome in a Pregnant Woman and Her Infant in Kosovo: A Case Report.

Crimean-Congo hemorrhagic fever: Strategies for diagnosis at initial admission.

Two Human Infections with Diverse Europe-1 Crimean-Congo Hemorrhagic Fever Virus Strains, North Macedonia, 2024.

Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spread.

Effectiveness of nucleoside analogs against Wetland virus infection.

Longitudinal seroprevalence of Crimean-Congo hemorrhagic fever virus in Southern Uganda.

Elucidating Infectious Causes of Fever of Unknown Origin: A Laboratory-Based Observational Study of Patients with Suspected Ebola Virus Disease, Guinea, 2014.

Identification and optimization of a small molecule inhibitor of the ovarian tumor protease of the Crimean-Congo hemorrhagic fever virus.

Hidden threats: Brucellosis diagnosis and co-infection patterns in Crimean-Congo Hemorrhagic Fever suspects.

Lift-CM: An integrated lift-heater centrifugal microfluidic platform for point-of-care pathogen nucleic acid detection using isothermal amplification and CRISPR/Cas12a.